Veridex, a Johnson & Johnson company, is an organization dedicated to providing physicians with high-value in vitro diagnostic oncology products. The company s products can benefit patients through earlier disease detection and may enable personalized strategies to help improve patient management and outcomes. Among its products are CellSearch and GeneSearch. CellSearch is a simple blood test that can be an independent predictor of survival, provide greater insight than standard tests alone and indicate a change in prognosis. GeneSearch is the first-FDA approved molecular diagnostic assay for breast lymph node testing which offers a chance for fewer second surgeries and hospital stays, rapid, reproducible and objective results, and analyzing up to 50 percent of the lymph node. Veridex maintains a location in Raritan, N.J.